Unsure what health diagnostics your business should offer? Explore the top 10 diagnostic tools telehealth platforms need to drive growth and value.
Discover the best medspa supplement categories to help improve client outcomes and drive better LTV.
The FDA's PCAC is reviewing 7 peptides July 23-24. Here's what the meeting is, what it actually means, and what comes next.
Learn what 503A compounding pharmacies are and their standards in this overview for healthcare organizations offering compounded medication programs.
May 2026 digital health trends, including AI drug discovery, CMS/FDA pathways, wearable tech, and investment in scalable, patient-centered care.
Explore the pros and cons of a white-label peptide therapy partner and what to consider when evaluating a turnkey peptide program.
Top gym supplements driving demand—protein, creatine, collagen, amino acids—and how gyms can turn interest into recurring revenue.
Learn how to offer peptides legally and compliantly while building and scaling a successful peptide therapy program.
Wondering what happens if FDA Category 2 peptides move to Category 1? This article explores what may occur based on 503A interim compounding policy.
Learn how telehealth leaders can use data to improve patient retention, reduce no-shows, and identify drift signals early.
The peptide therapeutics market is projected to nearly double by 2033. Discover what’s driving this growth and how businesses can get prepared.
Learn what FDA Category 1 peptides are, what the designation means for compounding, and how providers can offer them compliantly via 503A pharmacies.